Free shipping on Orders over $50Try a  sample pack
Cart0Item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.
Swipe to the left

AKA News

Oregon Approves the Kratom Protection Act

By TKS 3 months ago 284 Views No comments

 Unanimous approval of the Oregon State Senate Judiciary Committee of the provisions of the Kratom Consumer Protection Act that allows the bill to move to consideration by the Senate Ways and Means Committee.

You can view the pdf here https://legiscan.com/OR/text/SB1005/id/1999377/Oregon-2019-SB1005-Engrossed.pdf

Kratom Consumer Protection Act being adopted

By Blogger W 4 months ago 319 Views No comments

Georgia just passed there own version. 

Sponsored by Representatives Hill, Caldwell, Jones, Mathiak, and Newton, the Georgia version of the Kratom Consumer Protection Act does the following:

  • Restricts kratom sales to kids under the age of 18
  • Requires clear labeling of kratom products labels that shows:
    • The amount of mitragynine and 7-hydroxymitragynine in the product
    • A list of each ingredient listed in order of predominance
    • Clear directions for use
    • Precautionary statements on the safety and effectiveness of the product
    • The name and address of the manufacturer

 

It's great to see progress being made to clear out the bad actors and protect comsumers. Hopefully more states will follow and the FDA will look at the science and the vendors in the industry will rapidly adopt cGMP standards.  

 

8 factor analysis of kratom

By Admin 8 months ago 1447 Views No comments

The purpose of this document is to review the data related to the abuse potential and toxicity of Mitragyna speciosa (also known as kratom) and its primary alkaloids, mitragynine (MG) and 7-hydroxy-mitragynine (7-OH-MG), and the relevance of those data to the doses found in kratom.


We do not recommend scheduling of kratom or any of its specific alkaloids under the Controlled Substances Act. Kratom has a low potential for abuse and a low dependence liability and there is insufficient evidence of personal harm, adverse health effects or detriment to the public health to warrant control under the CSA.

Effectively banning the availability of kratom through scheduling could precipitate public health problems that do not presently exist or are at very low levels, because this would shift the market place from a largely lawful retail market to illicit manufacturers and distributors with no regulated labeling, purity or content standards, or effective ability to remove adulterated products from the market. Appropriate regulation of kratom under the FDCA is the most effective way to protect the public health by ensuring appropriate access and oversight and to sustain the overall very low adverse personal and public health effects associated with kratom consumption.

AKA cGMP Program

By System Administrator 8 months ago 860 Views 1 comment
AKA established this program to protect kratom consumers from vendors who produce kratom products using sloppy manufacturing procedures that allows for contamination, and will exclude vendors who deliberately adulterate kratom products to boost their effect by adding dangerous and sometimes deadly substances like fentanyl or morphine.